GlobeNewswire

NRT Acquires NCC, Leading Provider of Next Generation Credit Marker and AML Information Services to Global Gaming Operators

Dela

NCC is a strong addition to the NRT family of businesses, enabling the company to fortify a leading position in casino credit platforms and further enhancing NRT's value proposition by providing casino operators opportunities to grow revenue, reduce risk, meet compliance regulations, and better serve their VIP guests.

LAS VEGAS, April  11, 2018  (GLOBE NEWSWIRE) -- NRT Technology Corp. ("NRT"), a global technology leader of current and next generation payment systems, specialized financial/marketing self-serve kiosks, and digital and mobile experiences, announced that it has acquired the assets of privately held National Cred-A-Chek, Inc. ("NCC")  the leading provider of information services for underwriting credit markers to more than 300 casino operators around the world. Terms of the agreement were not disclosed.

The NCC acquisition follows closely on the heels of NRT's recently announced eMarker® acquisition, a solution which uses mobile technology and digital signatures to eliminate the cumbersome process of managing paper-issued casino markers, thereby expediting the marker process for casinos and their patrons.

NCC is a versatile and essential source of data on which casinos rely to make informed decisions regarding the underwriting of credit markers for their guests. By leveraging this powerful FCRA-compliant (Fair Credit Reporting Act) cloud-based platform in conjunction with eMarker®, NRT will become the first and only end-to-end solution for credit application hosting, bank verification data, gaming credit history data, third-party credit bureau data, ID validation, AML compliance, issuance, processing, storage, redemption, and repayment of casino markers.

"NCC is a great company with a long and successful history of using data and technology to deliver unparalleled insight into casino guests and their credit worthiness," said Christine Landis, President of NCC. "Our service goes back 40 years, and it has been a privilege to carry on Diane Hunt's legacy. Now is the right time to pass it off to a forward-thinking management team that can leverage our global operating model and technology platform."

"This acquisition opens an exciting opportunity and is a strong fit for NRT.  It reinforces our strategic focus to be a leading global casino information and data analytics solutions provider," said John Dominelli, NRT's Founder and President. "We're delighted to count on the expertise of NCC's management and staff, and we welcome them into the NRT family."

NRT's recent investment in Gaming Analytics.AI will further set the stage for the next evolution of technology enhancements for the gaming industry, allowing NRT to incorporate AI search-driven analytics with insights and contexts of marker player behavior and preferences.

"NCC and eMarker together create a groundbreaking end-to-end marker underwriting and issuance solution for casinos," said Kirk Sanford, Sightline Payments Founder and CEO. "Through NCC, we will have a robust platform connected to hundreds of casinos from which to offer advanced data analytics services for underwriting processes and 'next generation' risk scoring information."

Mrs. Landis added, "Our immediate objective is consistency and continuity for our customers and the NCC team members. I will stay on through a transition period to bring all the benefits of the combined companies together as quickly as possible while ensuring that NCC's solutions remain as nimble and well-organized as ever, and to efficiently incorporate more capabilities to accelerate performance for our valued customers."

About NCC

For the past 40 years, NCC's mission has been to help our over 300 casino partners around the world to optimize risk-based decisions for underwriting of casino credit and to meet AML compliance requirements. Our FCRA-compliant cloud-based platform automates marker credit applications and consolidates multidimensional reports of casino marker, front money, and check cashing information, bank verification data, as well as third-party credit bureau, identity validation, and KYC tools.

About NRT & Sightline

On closing of the pending merger, NRT Sightline will be the global leader in the design and development of enterprise platforms for the gaming industry, including current and next generation payment systems, specialized self-serve financial/marketing kiosks, big data analytics utilizing artificial intelligence and gamification, credit marker information services, and digital and mobile experiences. Through our global family of companies, we enable more than 1 billion physical and digital commerce experiences at over 750 casino properties worldwide, including the top 25 largest casino corporations.  By seamlessly combining technological innovation with strategic partnerships, our companies create the most convenient, reliable, and secure omni-channel payment ecosystem for casino operators and their guests. NRT and Sightline have been recognized with numerous industry awards, including the coveted "Most Innovative Gaming Technology Product of the Year" for our Play+(TM) cloud-based cashless funding platform. Our collective solutions are used by casinos, lotteries, race and sports, banking & retailers around the world.

For further information about this acquisition, please contact:  Michael Dominelli, NRT's SVP Marketing mdominelli@nrttech.com

For more information about Sightline or its pending merger with NRT, please contact:  Omer Sattar, Sightline's EVP Strategic Relationships osattar@sightlinepayments.com




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: NRT Sightline via Globenewswire

Om

GlobeNewswire



Följ GlobeNewswire

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från GlobeNewswire

Karolinska Development's portfolio company Modus Therapeutics completes enrollment in Phase II study with sevuparin7.1.2019 12:00Pressmeddelande

STOCKHOLM, January 7, 2019. Karolinska Development's portfolio company Modus Therapeutics announces that the patient enrollment has been completed in the Phase II study with sevuparin in patients with sickle cell disease (SCD). The results from the study is expected in mid 2019. Modus Therapeutic's randomized, double blind study contains 140 SCD-patients with Acute Vaso Occlusive Crisis (VOC). It compares intravenously administered sevuparin with placebo. The primary endpoint of the study is the demonstration of a reduced time to resolution of patient's VOC. Clincal sites across Europe and the Middle East took part in the study that was conducted in conjunction with Modus Therapeutics' co development partner Ergomed. SCD has a high unmet medical need as there are currently no approved therapies for VOCs. It is an inherited blood disorder that affects between 90,000 to 100,000 patients in the U.S. and is characterized by severely painful VOCs that lead to organ damage due to a lack of o

Karolinska Development's portfolio company Modus Therapeutics completes enrollment in Phase II study with sevuparin7.1.2019 12:00Pressmeddelande

STOCKHOLM, January 7, 2019. Karolinska Development's portfolio company Modus Therapeutics announces that the patient enrollment has been completed in the Phase II study with sevuparin in patients with sickle cell disease (SCD). The results from the study is expected in mid 2019. Modus Therapeutic's randomized, double blind study contains 140 SCD-patients with Acute Vaso Occlusive Crisis (VOC). It compares intravenously administered sevuparin with placebo. The primary endpoint of the study is the demonstration of a reduced time to resolution of patient's VOC. Clincal sites across Europe and the Middle East took part in the study that was conducted in conjunction with Modus Therapeutics' co development partner Ergomed. SCD has a high unmet medical need as there are currently no approved therapies for VOCs. It is an inherited blood disorder that affects between 90,000 to 100,000 patients in the U.S. and is characterized by severely painful VOCs that lead to organ damage due to a lack of o

Stillfront Group rekryterar ansvarig för M&A19.12.2018 12:07Pressmeddelande

PRESSMEDDELANDE 19 december, 2018 Stillfront Group rekryterar ansvarig för M&A Stillfront Group, en marknadsledare inom 'free to play' online strategispel, annonserar idag att Marina Andersson har utsetts till ansvarig för M&A och kommer att ingå i koncernledningen. Marina har närmare tjugo års erfarenhet från investment banking och M&A. Hon har omfattande erfarenhet inom strategisk och finansiell rådgivning, affärsgenerering, projektledning inom förvärv och försäljningar av företag, finansiell analys, due diligence, samt företagsvärdering. Tidigare positioner inkluderar: Director, Deloitte's Corporate Finance Advisory team, Director, ICECAPITAL Securities, Associate Partner och Investment Manager, Deseven, samt M&A Analytiker på Carnegie. Marina har två magister-examen från Stockholms universitet och Russian Herzen State Pedagogical University. "Förvärv är en viktig del av Stillfronts affärsstrategi och vi är mycket glada att rekrytera Marina Andersson. Marinas breda erfarenhet och pr

Stillfront Group announces Head of M&A19.12.2018 12:07Pressmeddelande

PRESS RELEASE December 19, 2018 Stillfront Group announces Head of M&A Stillfront Group, a market leader in 'free to play' online strategy games, today announces that Marina Andersson has been appointed as Head of M&A and will be part of the Group's management team. Marina has close to 20 years track record of investment banking and M&A. She has extensive competence within strategic and financial advisory, deal generation, buy and sell side M&A project management, financial analysis, due diligence and company valuation. Former positions include: Director at Deloitte's Corporate Finance Advisory team, Director at ICECAPITAL Securities, Associate Partner and Investment Manager at Deseven, M&A Analyst at Carnegie. She holds two Master degrees from Stockholm University and Russian Herzen State Pedagogical University. "Acquisitions are a crucial part of Stillfront's business strategy and we are very pleased with the appointment of Marina Andersson. Marina's breadth of experience and profess

Oboya tecknar ett samarbetsavtal med Gaia avseende biomaterial13.12.2018 11:41Pressmeddelande

Oboya Horticulture Industries AB (publ) ("Oboya") har tecknat ett viktigt och långsiktigt samarbetsavtal avseende miljövänligt biomaterial med Gaia Biomaterials AB ("Gaia") i Helsingborg, Sverige. Avtalet innebär att Oboya använder Gaias biomaterial för tillverkning och utveckling av miljövänliga odlingsprodukter till odlingsindustrin. Oboya har under de senaste åren arbetat aktivt med innovation, miljö- och hållbarhetsfrågor och vårt mål är att främja miljö och hållbarhet inom odlingsindustrin genom att erbjuda miljövänliga odlingsprodukter till våra kunder. Oboya anser att användningen av biomaterial kommer att vara viktigt för framgång i omställningen till en fossilfri odlingsindustri världen över. Samarbetsavtalet innebär att Oboya använder Gaias biomaterial i sin produktion och att vi genom Gaias kompetens kan utveckla nya miljövänliga odlingsprodukter. Gaias biomaterial är biologiskt nedbrytbart, komposterbart samt ger upp till 80 % lägre koldioxidutsläpp vid förbränning jämfört

Oboya signs a cooperation agreement with Gaia regarding biomaterials13.12.2018 11:41Pressmeddelande

Oboya Horticulture Industries AB (publ) ("Oboya") has signed an important and long-term cooperation agreement on environmentally friendly biomaterials with Gaia Biomaterials AB ("Gaia") in Helsingborg, Sweden. The agreement means that Oboya uses Gaias biomaterials for the production and development of environmentally friendly cultivation products for the cultivation industry. Oboya has been actively involved in innovation, environmental and sustainability issues in recent years, and our goal is to encourage environmental and sustainability in the cultivation industry by offering environmentally friendly cultivation products to our customers. Oboya believes that the use of biomaterials will be important for success in the conversion to a fossil-free cultivation industry worldwide. The cooperation agreement means that Oboya uses Gaias biomaterials in its production and that through Gaias expertise we can develop new environmentally friendly cultivation products. Gaias biomaterials are bi

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum